For Trump it was an anti-Covid cure, in reality hydroxychloroquine may have caused the deaths of around 17,000 people during the pandemic. Politico writes it… Already a subscriber? Login here!
SPECIAL OFFER
BEST OFFER
YEARLY
€79.99
19€
for 1 year
CHOOSE NOW
MONTHLY
€6.99
€1 PER MONTH
For 6 months
CHOOSE NOW
SPECIAL OFFER
SPECIAL OFFER
MONTHLY
€6.99
€1 PER MONTH
For 6 months
CHOOSE NOW
– or –
Subscribe by paying with Google
Subscribe to
SPECIAL OFFER
Read the article and the entire website ilmessaggero.it
1 year for €9.99 €89.99
Subscribe with Google
or
€1 per month for 6 months
Automatic renewal. Disable it whenever you want.
- Unlimited access to articles on the website and app
- The Good Morning newsletter at 7.30am
- The Ore18 newsletter for the day's updates
- The podcasts of our signatures
- Insights and live updates
For Trump card it was an anti-CovidIn reality, hydroxychloroquine may have caused the deaths of about 17,000 people during the pandemic. Politico writes this citing a study by French researchers published in the journal Biomedicine & Pharmacotherapy. The anti-malarial drug was prescribed during the first wave of the pandemic to some patients who were hospitalized without scientific documentation, and the study showed that thousands of people may have died as a result France, Belgium, Italy, Spain, Türkiye and the United States. This number may be an understatement considering that the researchers only examined six countries in a period from March to July 2020. The then US President Donald Trump also considered the drug a “miracle cure”. “What do you have to lose? Take it,” he said at the time.
The drug promoted by Trump
During the pandemic, Trump has repeatedly “advocated” the so-called benefits of hydroxychloroquine, an antimalarial drug also commonly used to treat rheumatoid arthritis and lupus, to treat the virus, saying he has taken it himself. At the time, some studies suggested that hydroxychloroquine might be helpful, but it had not been shown to be effective in treating the coronavirus. The Food and Drug Administration (FDA) granted the drug emergency use authorization on March 28, 2020 and began clinical trials.
Geopolitical risks in 2024: the two wars (Ukraine-Russia and Israel-Hamas), the Trump-Biden challenge and inflation. Fifty countries to vote
Subsequent larger studies, including one in the New England Journal of Medicine, found it had no benefit for the coronavirus and led to a significantly increased risk of death. The FDA revoked the emergency use authorization on June 15, 2020. The new study by French researchers found that nearly 17,000 people may have died during the first wave of Covid after receiving prescriptions for hydroxychloroquine in hospitals.
Research
The study, published in the February issue of Biomedicine & Pharmacotherapy, estimates that between March and July 2020, about 16,990 people in six countries died from prescription hydroxychloroquine while hospitalized with the disease. Most of these deaths involved patients from the United States, with 12,739 deaths. There were 1,895 deaths in Spain, 1,822 in Italy, 240 in Belgium, 199 in France and 95 in Turkey. The drug's toxicity was partly due to cardiac side effects. In fact, hydroxychloroquine is known to have side effects such as cardiac arrhythmias and muscle weakness.
Read the full article
on Il Messaggero